Azitra (AZTR) Revenue (2022 - 2024)
Azitra (AZTR) posted Revenue of $7500.0 for Q2 2024, down 91.67% quarter-over-quarter from $90000.0 in Q4 2023, and down 95.64% year-on-year from $172000.0 in Q3 2023.
Azitra (AZTR) Revenue (2022 - 2024) Analysis & Trends
Azitra (AZTR) has reported Revenue for 3 consecutive years, with $7500.0 the latest figure, recorded in Q2 2024.
- Revenue for Q2 2024 came in at $7500.0, down 95.64% year-over-year; the trailing twelve-month figure through Jun 2025 was $7500.0 (down 98.16% YoY), and the FY2024 annual result was $7500.0, down 98.91% from the prior year.
- Revenue was $7500.0 for Q2 2024 at Azitra, down from $90000.0 in the prior quarter.
- Over five years, Revenue peaked at $310700.0 in Q3 2023 and troughed at $7500.0 in Q2 2024.
- Average Revenue over 3 years is $107187.5, with a median of $87500.0 recorded in 2022.
- Year-over-year, Revenue jumped 540.62% in 2023 and plunged 95.64% in 2024.
- Over 3 years, Revenue stood at $30500.0 in 2022, then soared by 195.08% to $90000.0 in 2023, then plunged by 91.67% to $7500.0 in 2024.
- Per Business Quant data, the three most recent Revenue figures were $7500.0 in Q2 2024, $90000.0 in Q4 2023, and $310700.0 in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Genmab A | 276,399.99 Bn | 276,398.47 Bn | 831.00 Mn | 896.00 Mn |
| 2 | Akari Therapeutics | 1,217.26 Bn | 1,217.26 Bn | - | - |
| 3 | BeOne Medicines | 419.38 Bn | 414.59 Bn | 1.35 Bn | 1.51 Bn |
| 4 | Vertex Pharmaceuticals | 126.54 Bn | 119.30 Bn | 2.59 Bn | 2.99 Bn |
| 5 | Pharming | 110.17 Bn | 110.12 Bn | 65.80 Mn | 72.45 Mn |
| 6 | Regeneron Pharmaceuticals | 64.97 Bn | 56.22 Bn | 3.31 Bn | 3.61 Bn |
| 7 | Argenx Se | 56.44 Bn | 56.44 Bn | 1.18 Bn | 1.30 Bn |
| 8 | Alnylam Pharmaceuticals | 40.09 Bn | 37.08 Bn | 959.66 Mn | 1.17 Bn |
| 9 | Revolution Medicines | 37.15 Bn | 37.15 Bn | - | - |
| 10 | Azitra | 2.64 Mn | 2.64 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 7,500.00 |
| Dec 31, 2023 | 90,000.00 |
| Sep 30, 2023 | 310,700.00 |
| Jun 30, 2023 | 172,000.00 |
| Mar 31, 2023 | 113,300.00 |
| Dec 31, 2022 | 30,500.00 |
| Sep 30, 2022 | 48,500.00 |
| Jun 30, 2022 | 85,000.00 |